Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

August 2, 2021

Study Completion Date

October 4, 2021

Conditions
Gestational MotherStreptococcus Agalactiae Infection
Interventions
DIETARY_SUPPLEMENT

Lactobacillus salivarius V4II-90

7 months intervention study: with a screening period of 12 weeks after which participants GBS+ women will be randomized and start the orally intake of 1 capsule per day of the Lactobacillus salivarius V4II-90 (1\*10E9 CFU) probiotic supplement over a 12 weeks period. A visit will then be completed one month after delivery.

DIETARY_SUPPLEMENT

Placebo

7 months intervention study: with a screening period of 12 weeks after which participants GBS+ women will be randomized and start the orally intake of 1 capsule per day of the placebo supplement over a 12 weeks period. A visit will then be completed one month after delivery.

Trial Locations (1)

28046

Hospital Universitario La Paz, Madrid

All Listed Sponsors
collaborator

Casen Recordati S.L.

INDUSTRY

lead

ProbiSearch SL

INDUSTRY

NCT03669094 - Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women | Biotech Hunter | Biotech Hunter